State of Wisconsin Investment Board’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-44,627
| Closed | -$306K | – | 2351 |
|
|
2023
Q3 | $306K | Buy |
44,627
+7,053
| +19% | +$48.3K | ﹤0.01% | 2040 |
|
|
2023
Q2 | $390K | Sell |
37,574
-1,946
| -5% | -$20.2K | ﹤0.01% | 1898 |
|
|
2023
Q1 | $320K | Sell |
39,520
-4,401
| -10% | -$35.6K | ﹤0.01% | 2062 |
|
|
2022
Q4 | $692K | Sell |
43,921
-2,881
| -6% | -$45.4K | ﹤0.01% | 1733 |
|
|
2022
Q3 | $737K | Sell |
46,802
-1,636
| -3% | -$25.8K | ﹤0.01% | 1720 |
|
|
2022
Q2 | $676K | Sell |
48,438
-7,862
| -14% | -$110K | ﹤0.01% | 1911 |
|
|
2022
Q1 | $971K | Hold |
56,300
| – | – | ﹤0.01% | 1646 |
|
|
2021
Q4 | $819K | Hold |
56,300
| – | – | ﹤0.01% | 1513 |
|
|
2021
Q3 | $1.01M | Hold |
56,300
| – | – | ﹤0.01% | 1441 |
|
|
2021
Q2 | $989K | Buy |
+56,300
| New | +$989K | ﹤0.01% | 1455 |
|
|
2019
Q3 | – | Sell |
-36,800
| Closed | -$81K | – | 1541 |
|
|
2019
Q2 | $81K | Buy |
36,800
+800
| +2% | +$1.76K | ﹤0.01% | 1526 |
|
|
2019
Q1 | $216K | Buy |
36,000
+8,200
| +29% | +$49.2K | ﹤0.01% | 1457 |
|
|
2018
Q4 | $205K | Hold |
27,800
| – | – | ﹤0.01% | 1455 |
|
|
2018
Q3 | $404K | Buy |
27,800
+12,800
| +85% | +$186K | ﹤0.01% | 1436 |
|
|
2018
Q2 | $300K | Hold |
15,000
| – | – | ﹤0.01% | 1398 |
|
|
2018
Q1 | $263K | Hold |
15,000
| – | – | ﹤0.01% | 1379 |
|
|
2017
Q4 | $370K | Hold |
15,000
| – | – | ﹤0.01% | 1331 |
|
|
2017
Q3 | $387K | Hold |
15,000
| – | – | ﹤0.01% | 1342 |
|
|
2017
Q2 | $407K | Buy |
+15,000
| New | +$407K | ﹤0.01% | 1330 |
|